Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

Bio-Rad Laboratories

  • Page 1 of 1 (5 items) 1 

New Chromatography Software for Protein Purification

Bio-Rad Laboratories

ChromLab™ Software Version 4.0 has been updated to be used with next-generation chromatography (NGC) systems. The new software version continues the ChromLab legacy of enabling researchers to purify their proteins with ease. Beyond sim...

Maternal Serum II Control

Bio-Rad Laboratories

Liquichek Maternal Serum II Control is a frozen liquid human serum-based material designed to monitor the precision of laboratory test procedures used during maternal serum second trimester screening. Liquichek Maternal Serum II Control includes...

Diagnostic dPCR

Bio-Rad Laboratories

The QX200 Droplet Digital™ PCR (ddPCR™) System is used to partition a ddPCR reaction mixture into thousands of nanoliter-sized droplets. After each endpoint PCR on a thermal cycler, droplets are read individually as they are ...

Reverse Transcription ddPCR Kit

Bio-Rad Laboratories

The One-Step RT-ddPCR Advanced Kit for Probes is the latest offering for Droplet Digital™ PCR (ddPCR) reagents. In 2012, a new paradigm was introduced by which researchers could achieve absolute measure of target RNA molecules by combi...

Antibodies for Western Blotting

Bio-Rad Laboratories

PrecisonAb™ Antibodies offer sensitivity, specificity, and reliability to help researchers improve their Western blotting results. The antibodies come with complete validation data so researchers can accurately assess the antibodies&am...

  • Page 1 of 1 (5 items) 1 

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »